Compare Firy Inc. (FIRY) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Firy Inc. vs Natera Inc. Common Stock — how do they compare? Firy Inc. trades at $11.27 (market cap $206.28M), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 276.5× Firy Inc.'s market cap, and Firy Inc. is more actively traded (112,784 versus 1,131,157). Which is the better fit depends on your goals — on Pluang, investors hold Firy Inc. for 13 Days and Natera Inc. Common Stock for 0 Days on average.
| FIRY | NTRA | |
|---|---|---|
Market Cap | $206.28M | $57.03B |
Volume | 112,784 | 1,131,157 |
Sector | Technology | Health |
52-Week High | $13.10 | $425.64 |
52-Week Low | $2.28 | $179.42 |
Typical Hold Time | 13 Days | 0 Days |
Enterprise Value | $174.88M | $56.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIRY (formerly Skillz Inc.) trades at $11.17, down 9.85% in the last session. The technical outlook is bullish based on moving averages, though oscillators are neutral. Fundamentally, the company shows persistent losses with a net income margin of -60.23% despite an 87.76% gross margin. Recent developments include a $719 million legal victory and board additions, but cash burn remains a concern with negative operating cash flow of $68.93 million in 2025.
The outlook is cautious. While the legal win and strategic shifts offer potential upside, sustained losses and negative cash flow pose significant risks. Analyst sentiment is mixed with 60% hold ratings. Key catalysts include the collection of the legal judgment and improved operational efficiency, but investors face substantial execution and liquidity risks.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Firy Inc.
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
